###begin article-title 0
A dual role for integrin-linked kinase in platelets: regulating integrin function and alpha-granule secretion
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
Integrin-linked kinase (ILK) has been implicated in the regulation of a range of fundamental biological processes such as cell survival, growth, differentiation, and adhesion. In platelets ILK associates with beta1- and beta3-containing integrins, which are of paramount importance for the function of platelets. Upon stimulation of platelets this association with the integrins is increased and ILK kinase activity is up-regulated, suggesting that ILK may be important for the coordination of platelet responses. In this study a conditional knockout mouse model was developed to examine the role of ILK in platelets. The ILK-deficient mice showed an increased bleeding time and volume, and despite normal ultrastructure the function of ILK-deficient platelets was decreased significantly. This included reduced aggregation, fibrinogen binding, and thrombus formation under arterial flow conditions. Furthermore, although early collagen stimulated signaling such as PLCgamma2 phosphorylation and calcium mobilization were unaffected in ILK-deficient platelets, a selective defect in alpha-granule, but not dense-granule, secretion was observed. These results indicate that as well as involvement in the control of integrin affinity, ILK is required for alpha-granule secretion and therefore may play a central role in the regulation of platelet function.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 148 149 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 148 149 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B1">1</xref></sup>
###xml 232 233 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 232 233 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B1">1</xref></sup>
###xml 248 249 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 248 249 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B2">2</xref></sup>
###xml 413 414 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 415 416 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 413 416 410 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref></sup>
###xml 437 438 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 439 440 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 437 440 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref></sup>
###xml 468 469 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 468 469 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B7">7</xref></sup>
###xml 489 490 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 489 490 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B8">8</xref></sup>
###xml 508 509 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 508 509 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B9">9</xref></sup>
###xml 538 540 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 540 540 537 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11"/>
###xml 541 543 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 538 543 535 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B10">10</xref><xref ref-type="bibr" rid="B11"/>&#8211;<xref ref-type="bibr" rid="B12">12</xref></sup>
Integrin-linked kinase (ILK) was originally identified and cloned in 1996 as the result of a 2-hybrid screen for beta1-integrin-interacting proteins1 and is present in many tissues including heart, placenta, liver, kidney, pancreas,1 and platelets.2 Originally recognized for its ability to regulate integrin-mediated signal transduction, ILK has subsequently been shown to be involved in normal cardiac function,3,4 cardiac-hypertrophy,5,6 hepatocyte differentiation,7 dendrite formation,8 bone development,9 and several types of cancer.10-12
###end p 4
###begin p 5
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B1">1</xref></sup>
###xml 472 473 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 474 476 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 476 476 470 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14"/>
###xml 477 479 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 472 479 466 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B13">13</xref><xref ref-type="bibr" rid="B14"/>&#8211;<xref ref-type="bibr" rid="B15">15</xref></sup>
###xml 599 600 593 594 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 602 604 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 602 604 596 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B16">16</xref></sup>
###xml 634 635 628 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 770 772 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 773 775 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 770 775 760 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B17">17</xref></sup>
###xml 944 946 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 946 946 936 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19"/>
###xml 946 946 936 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20"/>
###xml 946 946 936 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21"/>
###xml 946 946 936 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22"/>
###xml 946 946 936 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23"/>
###xml 946 946 936 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24"/>
###xml 947 949 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 944 949 934 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B18">18</xref><xref ref-type="bibr" rid="B19"/><xref ref-type="bibr" rid="B20"/><xref ref-type="bibr" rid="B21"/><xref ref-type="bibr" rid="B22"/><xref ref-type="bibr" rid="B23"/><xref ref-type="bibr" rid="B24"/>&#8211;<xref ref-type="bibr" rid="B25">25</xref></sup>
###xml 1177 1179 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1177 1179 1167 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B26">26</xref></sup>
The structural characterization of this 59-kDa cytosolic protein implicates ILK in the coordination of cell signaling through its potential to interact directly and indirectly with receptors, cytoso-lic-signaling proteins, and cytoskeletal proteins across its 3 structurally conserved domains.1 The C terminus of ILK contains a serine-threonine kinase domain that binds to beta1- and beta3-containing integrins, parvin, paxillin (Hic5), kindlin (UNC-112 or MIG2) and PDK1.2,13-15 Adjacent to this is a pleckstrin homology domain that binds to phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3).16 The binding of PtdIns(3,4,5)P3 is thought to regulate kinase activity and facilitates interaction with alpha-parvin, which supports the formation of focal adhesions.13,17 At the N terminus of this molecule 4 ankyrin repeats bind to both ILK-associated phosphatase (ILKAP) and particularly interesting new cystine-histidine protein (PINCH).18-25 These interactions with integrins, intercellular signaling complexes and matrix proteins link the structural frameworks of the extracellular matrix (ECM) and the cytoskeleton and allow the transmission of bidirectional signals.26
###end p 5
###begin p 6
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 289 294 289 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref></sup>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 383 385 383 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B29">29</xref></sup>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 468 470 468 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B18">18</xref></sup>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 583 585 583 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B30">30</xref></sup>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 693 698 693 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B31">31</xref></sup>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 772 774 772 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B31">31</xref></sup>
###xml 103 109 <span type="species:ncbi:10090">murine</span>
###xml 720 725 <span type="species:ncbi:10090">mouse</span>
Debate has surrounded whether the cellular role of ILK involves kinase activity. Work in ILK-deficient murine endothelial cells and in HEK-293 cells, using siRNA to silence ILK expression, has demonstrated that ILK has a role in the phosphorylation of protein kinase B (PKB)/Akt at Ser473.27,28 This was confirmed by coimmunoprecipitation, mass spectrometry, and mutational analysis.29 The sequence of the kinase domain, however, is not well conserved between species,18 with sequence differences to other serine/threonine kinases found in the catalytic loop and conserved DXG motif.30 In some systems kinase dead mutations are still able to function or rescue function in ILK-deficient cells,26,31 and in ILK-deficient mouse fibroblasts PKB phosphorylation is unaffected.31 These discrepancies may underscore cell-specific and potentially species-specific differences in the mechanisms through which ILK contributes to cell function.
###end p 6
###begin p 7
###xml 607 609 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 607 609 592 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B32">32</xref></sup>
###xml 834 836 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 834 836 819 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B33">33</xref></sup>
###xml 1346 1348 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1346 1348 1303 1305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B34">34</xref></sup>
###xml 817 822 <span type="species:ncbi:10090">mouse</span>
Platelets play a fundamental role in hemostasis. Upon injury they become exposed to subendothelial matrix proteins, particularly collagens, to which they initially adhere via the GPIb-V-IX complex and plasma von Willebrand factor (VWF). This interaction with collagen is stabilized via direct interactions between platelet collagen receptor glycoprotein VI (GPVI) and integrin alpha2beta1. The binding of collagen to GPVI and receptor clustering results in the tyrosine phosphorylation of the FcR gamma-chain and triggers a signaling pathway that leads to PLCgamma2 phosphorylation and calcium mobilization.32 At sites of injury platelets are also exposed to thrombin generated due to the activation of the coagulation pathways, resulting in platelet signaling through the protease-activated receptors, PAR1 (PAR3 in mouse), and PAR4.33 Both signaling pathways result in cell spreading, positive feedback signaling, and signaling to other platelets. The latter occurs via secretion of thrombotic factors and inside-out integrin signaling, through which the affinity of integrins alpha2beta1 and alphaIIbbeta3 become increased. The bivalent binding of fibrinogen to integrin alphaIIbbeta3 supports platelet-platelet adhesion and hence thrombus formation. The resulting thrombus is stabilized by the increasing affinity of alpha2beta1 for collagen.34
###end p 7
###begin p 8
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 156 158 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B35">35</xref></sup>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 256 258 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B36">36</xref></sup>
###xml 545 547 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 548 550 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 545 550 541 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref></sup>
Platelets depend upon integrins for their role in hemostasis, as demonstrated by conditions where expression is reduced, such as Glanzmann thrombocytopenia.35 Through inside-out and outside-in signaling the integrins mediate a variety of cellular processes36 and are important in transduction pathways linking extracellular adhesive proteins (such as VWF, fibrinogen, and collagen), with intracellular signaling molecules (such as focal adhesion kinase [FAK] and paxillin) and cytoskeletal components (including talin, filamin, and alpha-actinin37,38).
###end p 8
###begin p 9
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
In this study a conditional ILK-deficient mouse model was used to examine the role of ILK in the regulation of platelet function, signaling, and thrombus formation under arterial flow conditions. The data indicate an important role for this molecule in the control of platelet biology.
###end p 9
###begin title 10
Methods
###end title 10
###begin title 11
Reagents
###end title 11
###begin p 12
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 150 152 150 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B39">39</xref></sup>
###xml 196 202 <span type="species:ncbi:9796">equine</span>
###xml 1029 1034 <span type="species:ncbi:10090">mouse</span>
###xml 1548 1554 <span type="species:ncbi:9986">rabbit</span>
###xml 1598 1604 <span type="species:ncbi:9986">rabbit</span>
###xml 1610 1615 <span type="species:ncbi:9606">human</span>
Collagen-related peptide (CRP), a GPVI-selective agonist was synthesized by Pepceuticals LTD (Nottingham, United Kingdom) and chemically cross-linked.39 Horm-Chemie collagen (collagen fibers from equine tendons) was purchased from Nycomed (Munich, Germany) and thrombin from Sigma (Poole, United Kingdom). Antibodies for immunoblotting: anti-ILK (C-19, sc-7516), anti-alpha2 (N-19, sc-6586), anti-alphaIIb (C-20, sc-6602), anti-beta1 (N-20, sc-6622), anti-beta3 (C-20, sc-6602), anti-PINCH1 (N-19, sc-47 914), anti-talin (C-20, sc-7534), and anti-PLCgamma2 (Q-20, sc-407) were purchased from Santa Cruz Biotechnology (Autogenbioclear; Calne, United Kingdom). Anti-P-selectin (RB40.34) was supplied by BD Biosciences, anti-phosphotyrosine (4G10) by Upstate (Millipore, Watford, United Kingdom), and anti-GAPDH (6C5), anti-kindlin polyclonal (ab36957), and anti-parvin alpha (ab11336) by AbCam (Cambridge, United Kingdom). For flow cytometry phycoerythrin (PE)-labeled CD62P (P-selectin) and fluorescein isothiocyanate (FITC) anti-mouse CD41 (integrin alphaIIb) were purchased from BD Biosciences. FITC-labeled fibrinogen was produced by incubating fibrinogen (2.5 mg/5 mL in phosphate-buffered saline [PBS]) in the dark with FITC (1 mg/mL in acetonitrile) in the presence of reaction buffer (PBS with 0.1% SDS, 1% triethylamine at pH 9) in a 1:1:1 ratio. The solution was gently mixed at 65degreesC in the dark for 30 minutes, and FITC-labeled fibrinogen then purified by ultrafiltration. Reagents used for the platelet factor 4 assay include: anti-rabbit (whole molecule)-peroxidase (Sigma A6154), rabbit anti-human platelet factor 4 (AYNRHPF4; Accurate Chemical & Scientific, Westbury, NY) and 3,3',5,5'-tetramethyl-benzidine (TMB) was from Sigma. The chemiluminescent Western blotting substrate was supplied by Pierce (Perbio, Cramlington, United Kingdom) and x-ray film by GE Healthcare (Little Chalfont, United Kingdom). Densitometry was performed using a BIO-RAD GS-710 calibrated imaging densitometer, and Quantity One analysis software. Fluo-4AM was from Invitrogen (Fisher Scientific, Loughborough, United Kingdom).
###end p 12
###begin title 13
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Generation of mice
###end title 13
###begin p 14
###xml 32 33 32 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 34 35 34 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 32 38 32 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B27">27</xref></sup>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 294 296 294 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B31">31</xref></sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
LoxP-flanked ILK-transgenic mice3,9,27 were crossed with mice containing a Cre transgene under control of the Mx1 promoter. Founders and breeding stock were backcrossed onto the C57BL6 genetic background and litters were genotyped by polymerase chain reaction (PCR) to select ILK(lox/lox):MxCre31 mice and littermate ILK(+/+):MxCre (control [Ctrl]) mice. All mice were given an intraperitoneal injection of 300 mug Poly(I)-Poly(C) (pIpC) 8 days prior to experiments.
###end p 14
###begin title 15
Preparation and aggregation of washed platelets
###end title 15
###begin p 16
###xml 496 497 494 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 500 501 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 525 526 523 524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 564 565 562 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 597 598 595 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 1024 1025 1009 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Blood was obtained from KO (ILK(lox/lox):MxCre) and control (ILK(+/+):MxCre) litter-matched mice via cardiac puncture following termination. Blood (1 mL) was drawn into a syringe containing acidic citrate dextrose (100 muL) (ACD; 120 mM sodium citrate, 110 mM glucose, 80 mM citric acid) as anticoagulant. Platelets were prepared from whole blood by differential centrifugation in the presence of prostacyclin (0.1 mug/ mL) and resuspended in modified Tyrode-HEPES buffer (134 mM NaCl, 0.34 mM Na2HPO4, 2.9 mM KCl, 12mM NaHCO3, 20 mM HEPES, 5 mM glucose, 1 mM MgCl2, pH 7.3) to a density of 8 x 108 cells/mL and rested for 30 minutes at 30degreesC prior to experiments. Platelets (90 muL) were stimulated with collagen at 37degreesC with continuous stirring (1200 rpm) in an optical aggregometer for 90 seconds. For aggregation experiments in platelet-rich plasma (PRP), blood was taken into citrate (3.13% [wt/vol]). PRP was collected and control and KO samples matched for platelet number (at a density no less than 2 x 108) and stimulated with collagen at 37degreesC with continuous stirring (1200 rpm) in an optical aggregometer. All protocols involving the use of animals were approved by the University of Reading Local Ethical Review Panel and are authorized by a United Kingdom Home Office License.
###end p 16
###begin title 17
Immunoblotting and immunoprecipitation
###end title 17
###begin p 18
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B40">40</xref></sup>
Immunoprecipitation, SDS-PAGE, and immunoblotting onto polyvinylidine difluoride membrane were all performed using standard techniques.40 Densitometry was performed using GAPDH levels to normalize for protein loading.
###end p 18
###begin title 19
Flow cytometry
###end title 19
###begin p 20
Surface integrin alphaIIbbeta3 levels were assessed with anti-alphaIIb (CD61) antibody and fibrinogen binding was measured using FITC-labeled fibrinogen. Surface exposure of P-selectin was observed as a measure of alpha-granule secretion using a PE-conjugated anti-CD62P (P-selectin) antibody. Flow cytometry was carried out on a FACScan system and analyzed using CellQuest software (Becton Dickinson, Oxford, United Kingdom).
###end p 20
###begin title 21
Dense granule secretion
###end title 21
###begin p 22
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 116 117 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 199 201 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 199 201 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B41">41</xref></sup>
Platelets (8 x 108 cells/mL) were loaded with [3H] 5-HT (37 kBq/mL) by incubation in PRP for 1 hour at 30degreesC. [3H] 5-HT secretion following activation was measured by scintillation spectrometry.41
###end p 22
###begin title 23
alpha-granule secretion: assay for platelet factor 4 (PF4)
###end title 23
###begin p 24
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 538 539 535 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 542 543 539 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 557 558 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 560 561 557 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 933 934 930 931 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 935 936 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1084 1085 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 785 791 <span type="species:ncbi:9986">rabbit</span>
Forty microliters of washed platelets at a density of 4 x 108 were stimulated with collagen (10 mug/mL) or thrombin (5 units/mL) for 90 seconds and stopped with 5 muL of 6% glutaraldehyde, then immediately centrifuged. Ten microliters of supernatant of lysed (maximum), resting and stimulated platelets were added in triplicate to 96-well plates containing 100 muL of binding buffer (50 mM 3-[cyclohexylamino]-1-propanesulfonic acid [CAPS] at pH 11.5). After incubating for 2 hours the plate was washed twice with wash buffer (0.165 mM Na2HPO4, 0.035 mM NaH2PO4, 1.5 mM NaCl) then blocked with 5% dried skimmed milk in TBS for 30 minutes. One hundred microliters of antiplatelet factor 4 antibody (10 ng/mL) was added to the wells for 1 hour and after 2 washes, 1:500 dilution of anti-rabbit peroxidase was added for 1 hour. Plates were washed 3 times and developer (3,3',5,5'-tetramethyl-benzidine [TMB] in 40% methanol and 0.015% H2O2) was added, color was allowed to develop for 15 minutes before 50 muL HCl (1 M) was added, and the plate was read at 450 nm on a Molecular Devices Emax precision microplate reader.
###end p 24
###begin title 25
Intracellular calcium mobilization analysis
###end title 25
###begin p 26
###xml 22 28 <span type="species:ncbi:10090">murine</span>
Fluo-4AM was added to murine PRP, prepared from whole blood by centrifugation, at a final concentration of 10 muM and incubated for 45 minutes at 30degreesC. Platelets were centrifuged and resuspended in Tyrode as normal and rested for 30 minutes. Fifty microliters of washed platelets were added to 96-well black-walled, clear-bottom microtiter plates (Greiner Bio-One, Frickenhausen, Germany). The plate was loaded into a Flexstation (Molecular Devices, Wokingham, United Kingdom) and allowed to equilibrate to temperature (37degreesC). CRP was then added to the plate to give 10 mug/mL final concentration (sufficient to stimulate full aggregation). Settings were: excitation 488 nm, emission 525 nm, reading sensitivity "normal," and photomultiplier tube (PMT) sensitivity "high." Run time was 180 seconds, with a fluorescence reading taken every 1.4 seconds. Analysis was performed using Softmax Pro software (Molecular Devices).
###end p 26
###begin title 27
Thrombus formation in whole blood under arterial flow conditions
###end title 27
###begin p 28
###xml 113 114 113 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 325 327 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B42">42</xref></sup>
###xml 459 461 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 985 986 983 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1157 1158 1155 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Platelets in whole blood were loaded with the lipophilic fluorescent dye 3,3'-dihexyloxacarbocyanine iodide (DiOC6; 0.5 ng/mL final) in 50% ethanol (0.05% [vol/vol] final) in the dark at room temperature for 30 minutes prior to perfusion. This had no effect on platelet aggregation (not shown), consistent with other reports.42 Whole blood was perfused through a collagen-coated (100 mug/mL) glass microcapillary using a syringe pump at a shear rate of 1000 s-1. Twenty microliters of Tyrode-HEPES buffer was then perfused though the system to remove unattached cells. The capillary was transferred to a Leica DMIRE2 inverted confocal microscope, and images were collected at room temperature through the thrombi at 2-mum intervals in the Z-plane (using N PLANL 20 x 0.4 objective lens with 0-2 mm correction) within 5 randomly selected fields of view. The resulting Z-stack data were analyzed using TCS SP2 software (Leica, Milton Keynes, United Kingdom) to calculate thrombus depth. t tests were performed using Microsoft Excel after confirming normality using SPSS software. Results are presented as mean values plus or minus standard error of the mean. P values of less than .05 were considered significant.
###end p 28
###begin title 29
Tail-bleeding assay
###end title 29
###begin p 30
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were anesthetized using ketamine (80 mg/kg) and xylazine (5 mg/kg) administered via the intraperitoneal route and placed on a heated mat. One millimeter of tail tip was removed using a scalpel blade and the tail tip bathed in sterile saline at 37degreesC. The time to cessation of bleeding was measured up to 10 minutes, after which the assay was terminated.
###end p 30
###begin title 31
Transmission electron microscopy
###end title 31
###begin p 32
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B43">43</xref></sup>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 498 499 498 499 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 522 523 522 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 524 525 524 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 528 529 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 553 554 553 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 573 574 573 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 577 578 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 583 584 583 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 605 606 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 608 609 608 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Washed platelets were dually fixed with glutaraldehyde and osmic acid adapted from a method described by White.43 In summary, an equal volume of 0.1% glutaraldehyde in White saline was added to washed platelets in Tyrode buffer for 15 minutes at room temperature (RT), after which platelets were centrifuged at 800g for 5 minutes then resuspended in 0.3% (vol/vol) glutaraldehyde for 45 minutes at RT. Platelets were then washed in White saline (0.7% NaCl [wt/vol], 0.0375% KCl [wt/vol], 0.05% MgSO4 [wt/vol], 0.075% Ca[NO3]2 4H2O [wt/vol], 0.055% NaHCO3 [wt/vol], 0.01% Na2HPO4 . 7H2O [wt/vol], 0.003% KH2PO4 [wt/vol], trace Phenol red) and resuspended in 1% (wt/vol) osmium for 1 hour. Samples were then dehydrated by a graded series of acetone and embedded in EPON resin made as per the manufacturer's instructions (Agar; Stansted, United Kingdom). Sections of approximately 0.7 mum were produced and floated onto a formvar film strengthened with carbon, then stained with lead citrate for 15 minutes, washed in water, and observed on a Philips CM20 analytical TEM at ambient temperature, 80 kV and 25 K true magnification. The imaging medium was Kodak Electron image film, SO-163.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Production of conditional ILK-deficient mice
###end title 34
###begin p 35
###xml 126 128 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 126 128 112 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B32">32</xref></sup>
###xml 225 227 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 225 227 211 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B31">31</xref></sup>
###xml 295 297 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 295 297 281 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B44">44</xref></sup>
###xml 743 745 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 743 745 729 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B44">44</xref></sup>
###xml 1007 1015 993 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
###xml 1134 1138 <span type="species:ncbi:10090">mice</span>
The association of ILK with the integrins alpha2beta1 and alphaIIbbeta3 suggest that ILK may have a role in platelet function.32 The systemic deletion of the ILK gene is embryonically lethal in mice at 3 to 5 days' gestation.31 Therefore, a conditional deletion model based on the CRE-Lox system44 was used to enable the deletion of the ILK gene. A double transgenic mouse colony was established by crossing a mouse in which LoxP sites flank the ILK gene, with a mouse in which the Cre-recombinase gene was placed under the control of the Mx1 promoter. Upon intraperitoneal injection with Poly(I)-Poly(C) (pIpC), an antiviral-type response causes interferon-mediated activation of the Mx1 promoter and subsequent production of Cre-recombinase.44 This results in the site-specific recombination of LoxP sites and consequent removal of the ILK gene. Platelets have a rapid turnover and immunoblot analysis of platelet whole cell lysate indicated that 8 days after pIpC injection ILK protein was undetectable (Figure 1A). When the ILK-deficient (ILK(lox/lox):MxCre) and control (ILK(+/+):MxCre) litter mates were injected with pIpC, the mice showed no noticeable deterioration in health over the 8-day period.
###end p 35
###begin p 36
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aggregation is attenuated in ILK-deficient platelets</bold>
###xml 350 351 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 631 632 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1003 1004 997 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
Aggregation is attenuated in ILK-deficient platelets. The levels of ILK protein in control (Ctrl) ILK(+/+):MxCre and KO mice ILK(lox/lox):MxCre at 8 days after pIpC injection were assessed by immunoblotting, and a GAPDH reprobe was used to check for equal loading (A). Platelet counts in whole blood from control (Ctrl) and KO are plotted (B; n = 4, P = .98). Washed platelets from ILK KO and control (Ctrl) mice were stimulated with collagen at a final concentration of 100 mug/mL. A representative aggregation trace is shown (C), and the percentage aggregation is plotted from 3 replicate experiments (D; n = 3, mean +/- SEM; ***P < .005). Platelets in PRP from ILK KO and control (Ctrl) mice were matched for platelet number and stimulated with collagen at a final concentration of 100 mug/mL and monitored for 5 minutes. A representative aggregation trace is shown (E), and the percentage aggregation (where the control = 100%) is plotted from 3 replicate experiments (F; n = 3, mean +/- SEM; all **P < .05).
###end p 36
###begin title 37
Characterization of ILK-deficient platelets
###end title 37
###begin p 38
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 885 892 858 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 986 987 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1169 1170 1127 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1180 1187 1136 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1332 1334 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1332 1334 1288 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B45">45</xref></sup>
###xml 1501 1509 1457 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 580 585 <span type="species:ncbi:10090">mouse</span>
###xml 706 710 <span type="species:ncbi:10090">mice</span>
###xml 1241 1245 <span type="species:ncbi:10090">mice</span>
Blood from pIpC-injected control and ILK KO mice contained an equal number of platelets (Figure 1B). Platelet size was assessed by flow cytometry, no difference was detected between control and KO platelets (average diameter, 2.09 and 2.07 mum, respectively), although a small difference was noted from the non-pIpC-injected WT mice tested (average diameter, 2.12 mum). Due to their fundamental role in the functional responses of platelets, the levels of key adhesion receptors alpha2, beta1, beta3, alphaIIb integrin subunits and GPVI levels were verified in the control and KO mouse platelets along with key integrin and ILK-binding partners. When ILK-deficient platelets were compared with the control mice, no significant difference was observed in levels of alpha2, beta3, alphaIIb integrin subunits, GPVI levels, or the levels of integrin-associated proteins kindlin and talin (Table 1). A modest reduction in the levels of beta1 integrin subunit was observed (13.28% +/- 2.02%, P </= .05) and the expression levels of the ILK-binding partners PINCH1 and alpha-parvin were reduced in ILK-deficient platelets (by 66.8% +/- 10.3% and 38.6% +/- 8.9%, respectively, P </= .05; Table 1). Previous reports show that initially pIpC-injected mice suffer from thrombocytopenia, although platelet numbers are recovered by around day 6.45 The experiments described in this paper were carried out at 8 days after pIpC injection, and equivalent platelet numbers in KO and control littermates were observed (Figure 1B).
###end p 38
###begin p 39
Characterization of the ILK-deficient platelets
###end p 39
###begin p 40
Relative levels of key adhesion receptors in the KO platelets compared to control were determined by immunoblotting. Densitometric data are expressed as a percentage of the control following adjustment for equivalent protein levels using GAPDH (35 kDa).
###end p 40
###begin p 41
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Mean plus or minus SEM, n = 3-8; *P </= .05.
###end p 41
###begin title 42
Aggregation is attenuated in ILK-deficient platelets
###end title 42
###begin p 43
###xml 446 454 442 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 622 630 616 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 719 727 711 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 182 187 <span type="species:ncbi:10090">mouse</span>
The effect of ILK deficiency on platelet function was assessed. Aggregation in response to collagen was measured in ILK-deficient platelets and compared with sibling-matched control mouse platelets (Ctrl). In washed platelets aggregation was reduced substantially in the ILK-deficient platelets in comparison to controls at both low (10 mug/mL, not shown) and high concentrations (100 mug/mL) of collagen over 90 seconds (46% +/- 5.6% reduction, Figure 1C,D). This defect could not be rescued by the presence of plasma components since aggregation responses in PRP were also reduced substantially (54% +/- 8.3% reduction; Figure 1E,F) at 90 seconds and continued to be reduced over 5 minutes (16.9% +/- 9.4% reduction; Figure 1E,F).
###end p 43
###begin title 44
ILK is required for the up-regulation of integrin alphaIIbbeta3 function
###end title 44
###begin p 45
###xml 482 490 448 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 608 616 567 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
ILK is known to associate with the cytoplasmic tail of the beta1- and beta3-containing integrins. To determine whether the loss of ILK would affect the surface exposure of integrins, surface alpha2beta1 and alphaIIbbeta3 levels were measured by flow cytometry. In ILK-deficient platelets alpha2beta1 surface exposure was unaffected compared with control mice (data not shown). Surface alphaIIbbeta3 was reduced compared with control platelets in resting conditions (a 20% decrease; Figure 2A). Upon activation the surface exposure of alphaIIbbeta3 was increased but to a lesser extent than the control mice (Figure 2B). This resulted in a 35% decrease in the amount of surface alphaIIbbeta3, indicating that the level of recruitment of alphaIIbbeta3 to the surface is reduced in the absence of ILK.
###end p 45
###begin p 46
###xml 0 72 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ILK is required for the up-regulation of integrin &#945;IIb&#946;3 function</bold>
###xml 195 196 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 248 249 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 444 445 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 474 475 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
ILK is required for the up-regulation of integrin alphaIIbbeta3 function. The exposure of integrin alphaIIbbeta3 on the platelet surface was measured by flow cytometry in resting platelets (A; **P </= .01), and thrombin-stimulated platelets (B; ***P </= .01). Fibrinogen binding was assessed in the ILK-deficient and control (Ctrl) platelets using FITC-labeled fibrinogen and flow cytometry. Platelets were stimulated with either collagen (C; *P </= .05) or thrombin (D; ***P </= .005) (average reduction of 60% in the KO compared with the WT). Data for fibrinogen binding upon thrombin activation was normalized to account for the reduction in surface receptors (E). All data expressed as mean plus or minus SEM, n = 4.
###end p 46
###begin p 47
###xml 366 374 359 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 549 557 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
The up-regulation in affinity of alphaIIbbeta3 was monitored by flow cytometry to measure the binding of FITC-labeled fibrinogen to the platelet surface. Following stimulation with collagen or thrombin, a large increase in fibrinogen binding to control platelets was observed. ILK-deficient platelets, however, displayed only a small increase in fibrinogen binding (Figure 2C,E). The large reduction in fibrinogen binding in the ILK-deficient platelets was still apparent when data were normalized to account for the difference in receptor numbers (Figure 2E), indicating that ILK is involved in the up-regulation of the affinity of alphaIIbbeta3. A small increase in fibrinogen binding upon activation was, however, observed in the ILK-deficient platelets, indicating that either low-level integrin affinity up-regulation is possible in the absence of ILK or that residual ILK expression is maintained below the level of detection. Similar data obtained in response to both collagen and thrombin stimulation shows that ILK is involved in features of platelet activation common to both agonists.
###end p 47
###begin title 48
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Granule secretion is defective in ILK-deficient mice
###end title 48
###begin p 49
###xml 563 565 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 563 565 559 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B46">46</xref></sup>
###xml 706 714 702 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 832 840 828 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1114 1122 1106 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1319 1327 1303 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1640 1648 1601 1609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1743 1751 1704 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
The aggregation of washed platelets is dependent upon platelet granule secretion, which supplies fibrinogen that supports aggregation. Therefore the observed reduction in aggregation may be explained by a reduction in either integrin affinity or secretion, or a combination of both of these. After platelet stimulation with collagen the secretion of alpha-granules was assessed by monitoring the increase in surface P-selectin by flow cytometry. In control platelets collagen stimulated a dramatic increase in surface P-selectin, consistent with previous reports.46 ILK-deficient platelets, however, displayed substantially reduced surface P-selectin exposure following stimulation compared with controls (Figure 3A), while immunoblot analysis demonstrated that total P-selectin levels are unaltered in the ILK-deficient platelets (Figure 3B). To establish whether this was due to a defect in membrane assemblage into the alpha-granules or a secretion defect, the release of platelet factor 4 (PF4) was assessed. PF4 secretion was reduced in the ILK-deficient platelets when stimulated with collagen and thrombin (Figure 3C), consistent with an alpha-granule secretion defect. Furthermore, TEM analysis illustrated that the ILK-deficient platelets have normal ultrastructure, including the formation of alpha-granules (Figure 3D,E) that appear of normal size and number (control mean = 3.1 +/- 0.57 alpha-granules/platelet, KO mean = 3.3 +/- 0.40 alpha-granules/platelet). This reduction in alpha-granule secretion is consistent with the observed reduced recruitment of alphaIIbbeta3 to the platelet surface in the ILK-deficient platelets (Figure 2A,B) and indicates the presence of a major defect in secretion in the ILK-deficient platelets (Figure 3B).
###end p 49
###begin p 50
###xml 0 80 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;-granule but not dense granule secretion is defective in ILK-deficient mice</bold>
###xml 258 259 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 746 747 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 788 789 772 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 847 848 830 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 882 883 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 985 990 <span type="species:ncbi:10090">mouse</span>
alpha-granule but not dense granule secretion is defective in ILK-deficient mice. The exposure of P-selectin at the platelet surface was measured by flow cytometry in resting (basal) and stimulated (collagen 100 mug/mL) platelets (A; mean +/- SEM, n = 4; ***P </= .005). Western analysis of total cellular P-selectin (140 kDa) is shown in panel B. Densitometric analysis shows the protein levels of P-selectin are unchanged in the absence of ILK (n = 3, KO = 85.77% +/- 5.54%). Equivalent levels of protein loading were demonstrated by reprobing blots for GAPDH (B, bottom panel) (35 kDa). Release of platelet factor 4 (PF4) was measured in washed platelets stimulated with collagen (10 mug/mL) and thrombin (5 units/mL; C; mean +/- SEM, n = 4; *P </= .05). Washed platelets loaded with [3H] 5-HT were stimulated with collagen (10 mug/mL) (n = 3, P = .64) and thrombin (5 units/mL; P = .69; D) as a measure of dense granule secretion. TEM images of control (Ctrl; E) and KO (F) washed mouse platelets show normal formation of mitochondria (letter M), dense granules (letter D), alpha-granule (letter A), and glycerol stores (letter G) in the KO platelets.
###end p 50
###begin p 51
###xml 149 157 147 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 187 195 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 292 300 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
Dense granule secretion was examined using radiolabeled 5-hydroxytryptamine (5-HT). The analysis of collagen (100 mug/ mL (not shown) and 10 mug/mL [Figure 3D]) and thrombin (5 units/mL [Figure 3D]) mediated release of 5-HT revealed no difference between control and ILK-deficient platelets (Figure 3D), indicating that dense granule secretion is unaffected by ILK depletion. Thus, the observed reduction in aggregation is not due to reduced secretion of dense granule components such as adenosine diphosphate (ADP) that would normally perpetuate activation.
###end p 51
###begin title 52
Thrombus formation is diminished in ILK-deficient blood
###end title 52
###begin p 53
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 232 234 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 381 389 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 489 497 489 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 630 638 630 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 738 746 738 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 838 846 834 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 946 954 935 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
The effect of ILK depletion on thrombus formation under arterial flow conditions was assessed in an in vitro system. Whole blood labeled with DiOC6 was perfused through a collagen-coated capillary at an arterial shear rate of 1000 s-1 and the resulting thrombi assessed by confocal microscopy. In the ILK-deficient samples the number of thrombi formed was found not to be altered (Figure 4C), indicating that the level of initial adhesion is unaffected by the absence of ILK in platelets (Figure 4A,C). A decrease was observed, however, in the depth of thrombi formed in the ILK-deficient blood compared with the control samples (Figure 4B). This suggests that the assembly of large thrombi by platelet-platelet interactions was reduced (Figure 4A,B). This is consistent with the expected consequences of reduced alpha-granule secretion (Figure 3A) and reduced collagen-stimulated alphaIIbbeta3 affinity up-regulation in ILK-deficient platelets (Figure 2C,D).
###end p 53
###begin p 54
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thrombus formation is diminished in ILK-deficient blood</bold>
###xml 122 123 122 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 198 200 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 521 522 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 649 650 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Thrombus formation is diminished in ILK-deficient blood. Whole blood from KO and control (Ctrl) mice was labeled with DiOC6 and perfused through a collagen-coated capillary at a shear rate of 1000 s-1. Representative topological and composite (stacked) views of the thrombi formed (A) show more large thrombi are formed in the control (Ctrl) compared with the KO, though the KO sample still shows formation of many small plaques. (B) The average maximum depth of thrombi formed in a field of view (mean +/- SEM, n = 10; *P </= .05). The number of thrombi formed (C) was not significantly altered in the control and KO samples (mean +/- SEM, n = 10; P = .34).
###end p 54
###begin title 55
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with ILK-deficient platelets show extended bleeding
###end title 55
###begin p 56
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
To examine the effect of ILK depletion in platelets on hemostasis, tail bleeding assays were performed. Bleeding time and volume was prolonged moderately in ILK-deficient mice in comparison to the litter-mate controls, with almost all of the KO mice bleeding beyond the 10-minute duration of the assay (Figure 5).
###end p 56
###begin p 57
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bleeding time and volume is increased in the ILK KO mice</bold>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 371 372 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
Bleeding time and volume is increased in the ILK KO mice. The time to cessation of bleeding following transection of the tail tip of ILK-deficient and litter-matched control (Ctrl) was measured over 10 minutes. Data represent individual mice (n = 14) with the mean value indicated. *P < .05 (A). The volume of blood lost was assessed and is represented for individuals. *P < .05 (B).
###end p 57
###begin title 58
Early agonist-induced signaling is unaffected by the absence of ILK
###end title 58
###begin p 59
###xml 547 555 522 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 800 808 775 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1000 1008 975 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
PLCgamma2 tyrosine phosphorylation and calcium release precede both aggregation and alpha-granule secretion in collagen-stimulated (GPVI) signaling. To determine whether agonist induced signaling is initiated normally in ILK-deficient platelets, PLCgamma2 tyrosine phosphorylation and calcium mobilization levels were examined. PLCgamma2 was immunoprecipitated from resting and collagen-stimulated (100 mug/mL for 90 seconds) platelets and immunoblotted for tyrosine phosphorylation and total PLCgamma2 levels. PLCgamma2 tyrosine phosphorylation (Figure 6A,B) was unaltered in the ILK-deficient platelets compared with the controls. Calcium mobilization was observed by loading resting platelets with Fluo4-AM and measuring the change in fluorescence upon stimulation with CRP. Calcium mobilization (Figure 6C) was unaltered in the ILK-deficient platelets compared with controls. This demonstrated that early GPVI stimulated signaling leading to calcium mobilization was unaffected by ILK depletion (Figure 6).
###end p 59
###begin p 60
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Early agonist induced signaling is unaffected by the absence of ILK</bold>
###xml 414 415 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 757 758 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Early agonist induced signaling is unaffected by the absence of ILK. PLCgamma2 immunoprecipitated from ILK-deficient and control (Ctrl) washed platelets was prepared from resting and collagen-stimulated (100 mug/mL 90 seconds) samples. Samples were immunoblotted for tyrosine phosphorylation, stripped, and reprobed for PLCgamma2 loading levels, and densitometric analysis was carried out (A; mean +/- SEM, n = 3; P = .44). A representative blot of PLCgamma2 and tyrosine phosphorylation (4G10) levels is shown (B). Calcium mobilization in Fluo-4AM- labeled control (Ctrl) and ILK-deficient platelets was monitored in a Flexstation II, and change in fluorescence was expressed as the percentage increase in calcium from resting levels (mean +/- SEM, n = 3; P = .16; C).
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 173 174 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 175 177 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 178 180 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 173 180 167 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B32">32</xref></sup>
###xml 411 412 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 413 415 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 411 415 405 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B14">14</xref></sup>
###xml 574 575 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 574 575 568 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B2">2</xref></sup>
Previous work has shown that ILK physically interacts with beta1 and beta3 integrin subunits in platelets and that these interactions are increased upon platelet activation.2,14,32 Since these integrins play a major role in platelet function, adhering platelets to sites of damage and facilitating platelet-platelet interactions, it has been proposed that this association may be important to platelet function.2,14 Furthermore, it has been shown that ILK isolated from platelets exhibits kinase activity that is increased transiently upon collagen and thrombin stimulation.2
###end p 62
###begin p 63
###xml 253 261 253 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 469 476 458 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 495 503 484 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 641 649 627 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
To allow analysis of the role of ILK in platelet function and signaling, a conditional ILK knockout mouse model was established using the Cre-LoxP system. By day 8 following Cre-induction, ILK expression was reduced to undetectable levels in platelets (Figure 1A). Equivalent platelet numbers were observed in control and ILK KO mice, and levels of receptors were relatively unchanged in the platelets, including the integrin subunits alpha2, alphaIIb and beta3, GPVI (Table 1), and P-selectin (Figure 2D). Although a modest reduction in beta1 levels was observed, the adhesion of platelets to collagen under flow conditions was unaffected (Figure 4C). While integrin alpha2beta1 function has not been the focus of this study, preliminary experiments indicate that ILK-deficient platelets are able to spread on collagen and form filopodia and lamellipodia; however, the timing of this compared with control platelets has not been assessed.
###end p 63
###begin p 64
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 144 146 144 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B17">17</xref></sup>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 166 171 166 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B22">22</xref></sup>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
In other cell types ILK has been shown to bind directly to PINCH and parvin to form a complex known as the IPP that regulates integrin signaling17 and focal adhesion.19,22 Immunoblot analysis revealed that the expression of both proteins was reduced in the ILK-deficient platelets (Table 1), indicating that ILK is required to maintain full levels of these associated proteins, thus the phenotype may reflect the combined functions of these proteins.
###end p 64
###begin p 65
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B47">47</xref></sup>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 265 267 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B48">48</xref></sup>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 498 499 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B2">2</xref></sup>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 714 715 714 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B1">1</xref></sup>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 878 883 878 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref></sup>
###xml 313 318 <span type="species:ncbi:9606">human</span>
ILK has also been shown to be involved in interactions between the plasma membrane and the cytoskeleton.47 Indeed this plasma membrane-cytoskeleton interaction with ILK has been reported to be essential for shape change, adhesion, and spreading in other cell types.48 We have found previously that stimulation of human platelets with CRP or thrombin results in the translocation of ILK from the cytoplasm to the plasma membrane where it colocalizes with integrin subunits and the membrane skeleton.2 This movement to the surface and possibly the movement of associated proteins is likely to be important for ILK function. In other cell types ILK has been shown to regulate such changes in cytoskeleton arrangement.1 We therefore examined the protein expression levels of cytoskeleton and integrin-associated proteins kindlin and talin that are implicated in integrin regulation.49,50 No difference in protein levels of kindlin or talin was observed in the ILK-deficient platelets, although talin showed a trend toward decreased expression. This suggests that these proteins are not involved in the functional defects observed in this study.
###end p 65
###begin p 66
###xml 103 111 103 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 393 401 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 455 462 434 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 618 620 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 618 620 594 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B47">47</xref></sup>
###xml 763 771 732 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 812 820 781 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
ILK-deficient platelets showed reduced aggregation in both washed platelets and in PRP over 5 minutes (Figure 1C-F), demonstrating the importance of ILK in platelet function. To begin to assess why ILK-deficient platelets showed reduced function, integrin alphaIIbbeta3 surface exposure and affinity regulation were investigated. ILK depletion reduced slightly alphaIIbbeta3 surface exposure (Figure 2A) despite normal levels of alphaIIbbeta3 expression (Table 1). This is consistent with work on a skeletal muscle-restricted deletion of ILK that shows reduced localization of beta1 integrin to myotendinous junctions.47 The activation of alphaIIbbeta3 to a higher affinity binding state for fibrinogen was reduced markedly (data normalized for receptor numbers [Figure 2E]), although was not completely absent (Figure 2C-E), indicating that ILK has a significant role in alphaIIbbeta3 activation. Clot retraction studies indicated no difference between the control and ILK-deficient platelets (data not shown), suggesting that the reduction in alphaIIbbeta3 activation is unlikely to be explained by an outside-in signaling defect.
###end p 66
###begin p 67
###xml 233 241 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 280 288 276 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 435 443 427 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 463 471 455 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 693 701 685 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1041 1043 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1041 1043 1025 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B51">51</xref></sup>
Defective platelet aggregation could also be caused by reduced secretion during activation. Platelet alpha- and dense-granule secretion by ILK-deficient platelets were therefore examined. Despite normal levels of P-selectin protein (Figure 3B) and normal platelet ultrastructure (Figure 3E), a dramatic reduction in agonist-induced alpha-granule secretion in the ILK KO platelets was revealed by examining P-selectin surface exposure (Figure 3A) and PF4 release (Figure 3C). This defect was seen even at high concentrations of agonists and suggests a central role for ILK in platelet activation. Dense granule secretion, however, was maintained at both high and low concentrations of agonist (Figure 3C,D). Taken together these results suggest that this is not a general disruption of the structural changes that occur upon platelet activation and that alpha-granule secretion is specifically effected by ILK depletion. Differential secretion of alpha- and dense-granules from platelets via the actin cytoskeleton has been recently reported.51 It is possible, therefore, that ILK plays a critical role in aspects unique to alpha-granule secretion.
###end p 67
###begin p 68
###xml 140 148 136 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 376 384 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
The presence of fibrinogen (present in alpha-granules and plasma) did not rescue the reduction in aggregation observed in washed platelets (Figure 1E,F). These data suggest that the alphaIIbbeta3 affinity up-regulation defect alone would cause a reduction in function. However, the increased lag time observed in the PRP and washed samples containing ILK-deficient platelets (Figure 1C-F) may be due to reduced alpha-granule secretion and further activation resulting from this.
###end p 68
###begin p 69
###xml 210 218 210 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 511 519 504 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 580 588 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
The importance of ILK in thrombus generation in whole blood was investigated by studying thrombus formation on immobilized collagen under arterial flow conditions. The number of thrombi formed was not reduced (Figure 4C), suggesting that initial adhesion was not substantially affected by the absence of ILK. The depth of thrombi formed, however, was reduced in the blood of ILK-deficient mice (Figure 4B). This reduced thrombus growth is consistent with the reduced platelet alphaIIbbeta3 activation observed (Figure 2B). The moderately increased bleeding in ILK-deficient mice (Figure 5) indicates the physiological importance of ILK for normal platelet function.
###end p 69
###begin p 70
###xml 470 478 466 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
Since ILK appeared to possess a central role in the platelet activation process, it was important to establish that cell signaling was triggered following exposure to agonists. The phosphorylation of PLCgamma2 and the mobilization of calcium from internal stores following stimulation of the collagen receptor GPVI are events up-stream of granule secretion and integrin activation. Upon stimulation with collagen (or CRP) both events appear unaffected by ILK depletion (Figure 6), indicating that early collagen signaling events are not dependent on the presence of ILK and that the apparent defect in platelet signaling lies further downstream.
###end p 70
###begin p 71
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B17">17</xref>,</sup>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 407 412 407 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B22">22</xref></sup>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 486 491 486 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref></sup>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 599 603 599 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B15">15</xref></sup>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 658 660 658 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="B52">52</xref></sup>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
The changes to platelet signaling and function described here, as a result of ILK deficiency, may be as a direct result of loss of ILK kinase activity or ILK protein-protein interactions (or a combination of both of these). In other cells ILK has been shown to form associations with a complex of molecules, components of which include PINCH and parvin, that together with ILK regulate integrin signaling17,19,22 and have been shown to be necessary for the formation of focal adhesions.22,25 Through these and other interactions ILK is implicated in many processes including cytoskeletal arrangement1,15 cell adhesion, migration, survival, and proliferation.52 Further work will be required to establish the basis of the defects observed in ILK-deficient mice, and whether these result from disruption of protein complex formation and/or kinase activity.
###end p 71
###begin p 72
Our data provide compelling evidence that ILK has a role in the regulation of platelet function and suggests a dual role for ILK in the regulation of platelet function through the control of alpha-granule secretion and the affinity modulation of alphaIIbbeta3.
###end p 72
###begin p 73
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734.
###end p 73
###begin title 74
Acknowledgments
###end title 74
###begin p 75
The authors dedicate this work to the memory of Ms Susan Berresford for her valued contribution to this study.
###end p 75
###begin p 76
###xml 124 129 <span type="species:ncbi:10090">mouse</span>
The authors thank Molecular Devices in Wokingham and Dr Amanda Sadler for support and advice regarding calcium assays using mouse platelets, and Dr Chris Stain (Center for Advanced Microscopy, University of Reading) for advice on TEM imaging.
###end p 76
###begin p 77
###xml 207 211 <span type="species:ncbi:10090">mice</span>
This work was supported by grants from the Wellcome Trust (072498/z/03/z and 082338) and the British Heart Foundation (FS/03/076/15916, RG/05/007, and PG/2001/143). Support for engineering of the ILK-floxed mice was provided by a grant from the Shriners of North America to R.S.-A.
###end p 77
###begin title 78
Authorship
###end title 78
###begin p 79
###xml 160 175 <span type="species:ncbi:10090">transgenic mice</span>
Contribution: K.L.T., T.S., J.M.S., P.A.J., S.J., N.E.B., and J.M.G. participated in designing and performing the research; R.S.-A., J.F., and S.D. contributed transgenic mice used to create the conditional KO system; and K.L.T. and J.M.G. wrote the paper.
###end p 79
###begin p 80
Conflict-of-interest disclosure: The authors declare no competing financial interests.
###end p 80
###begin p 81
###xml 144 164 144 164 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k.l.tucker@rdg.ac.uk</email>
Correspondence: Katherine L. Tucker, School of Biological Sciences, University of Reading, Reading, Berkshire, RG6 6AJ, United Kingdom; e-mail: k.l.tucker@rdg.ac.uk.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Regulation of cell adhesion and anchorage-dependent growth by a new b1-integrin-linked protein kinase.
###end article-title 83
###begin article-title 84
###xml 44 49 <span type="species:ncbi:9606">human</span>
The regulation of integrin-linked kinase in human platelets: evidence for involvement in the regulation of integrin alpha 2 beta 1.
###end article-title 84
###begin article-title 85
###xml 34 40 <span type="species:ncbi:10090">murine</span>
Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure.
###end article-title 85
###begin article-title 86
###xml 114 123 <span type="species:ncbi:7955">zebrafish</span>
Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart.
###end article-title 86
###begin article-title 87
Role of the integrin-linked kinase/PINCH1/alpha-parvin complex in cardiac myocyte hypertrophy.
###end article-title 87
###begin article-title 88
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 102 117 <span type="species:ncbi:10090">transgenic mice</span>
Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice.
###end article-title 88
###begin article-title 89
Integrin-linked kinase is involved in matrix-induced hepatocyte differentiation.
###end article-title 89
###begin article-title 90
An essential role for the integrin-linked kinase-glycogen synthase kinase-3 beta pathway during dendrite initiation and growth.
###end article-title 90
###begin article-title 91
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Reduced chondrocyte proliferation and chondrodysplasia in mice lacking the integrin-linked kinase in chondrocytes.
###end article-title 91
###begin article-title 92
The integrin-linked kinase (ILK) suppresses anoikis.
###end article-title 92
###begin article-title 93
The role of integrin-linked kinase (ILK) in cancer progression.
###end article-title 93
###begin article-title 94
###xml 66 71 <span type="species:ncbi:9606">human</span>
Characterisation of integrin-linked kinase signalling in sporadic human colon cancer.
###end article-title 94
###begin article-title 95
Distinct roles of two structurally closely related focal adhesion proteins, alpha-parvins and beta-parvins, in regulation of cell morphology and survival.
###end article-title 95
###begin article-title 96
Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway.
###end article-title 96
###begin article-title 97
Possible role of ILK-affixin complex in integrin-cytoskeleton linkage during platelet aggregation.
###end article-title 97
###begin article-title 98
Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase.
###end article-title 98
###begin article-title 99
ILK, PINCH and parvin: the tIPP of integrin signalling.
###end article-title 99
###begin article-title 100
Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism.
###end article-title 100
###begin article-title 101
Integrin-linked kinase is localized to cell-matrix focal adhesions but not cell-cell adhesion sites and the focal adhesion localization of integrin-linked kinase is regulated by the PINCH-binding ANK repeats.
###end article-title 101
###begin article-title 102
Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes.
###end article-title 102
###begin article-title 103
Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1.
###end article-title 103
###begin article-title 104
The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells.
###end article-title 104
###begin article-title 105
Characterization of PINCH-2, a new focal adhesion protein that regulates the PINCH-1-ILK interaction, cell spreading, and migration.
###end article-title 105
###begin article-title 106
A critical role of the PINCH-integrin-linked kinase interaction in the regulation of cell shape change and migration.
###end article-title 106
###begin article-title 107
Assembly of the PINCH-ILK-CH-ILKBP complex precedes and is essential for localization of each component to cell-matrix adhesion sites.
###end article-title 107
###begin article-title 108
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane.
###end article-title 108
###begin article-title 109
Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.
###end article-title 109
###begin article-title 110
Integrin-linked kinase regulates endothelial cell survival and vascular development.
###end article-title 110
###begin article-title 111
Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase - Critical roles for kinase activity and amino acids arginine 211 and serine 343.
###end article-title 111
###begin article-title 112
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.
###end article-title 112
###begin article-title 113
Integrin-linked kinase (ILK) is required for polarizing the epiblast, cell adhesion, and controlling actin accumulation.
###end article-title 113
###begin article-title 114
Platelet adhesion signalling and the regulation of thrombus formation.
###end article-title 114
###begin article-title 115
###xml 59 64 <span type="species:ncbi:9606">human</span>
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
###end article-title 115
###begin article-title 116
Platelets interact with soluble and insoluble collagens through characteristically different reactions.
###end article-title 116
###begin article-title 117
Glanzmann thrombasthenia.
###end article-title 117
###begin article-title 118
Integrin signaling.
###end article-title 118
###begin article-title 119
Integrins: dynamic scaffolds for adhesion and signaling in platelets.
###end article-title 119
###begin article-title 120
Integrin regulation.
###end article-title 120
###begin article-title 121
Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity.
###end article-title 121
###begin article-title 122
The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor gamma-chain and linker for activitor of T cells (LAT) in platelets stimulated by collagen and convulxin.
###end article-title 122
###begin article-title 123
###xml 84 89 <span type="species:ncbi:9606">human</span>
Platelet endothelial cell adhesion molecule-1 signalling inhibits the activation of human platelets.
###end article-title 123
###begin article-title 124
Techniques to examine platelet adhesive interactions under flow.
###end article-title 124
###begin article-title 125
Electron microscopy methods for studying platelet structure and function.
###end article-title 125
###begin article-title 126
###xml 35 51 <span type="species:ncbi:10678">bacteriophage P1</span>
Site-specific recombination by the bacteriophage P1 lox-Cre system: Cre-mediated synapsis of two lox sites.
###end article-title 126
###begin article-title 127
###xml 142 144 142 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
The critical regulator of embryonic hematopoiesis SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12.
###end article-title 127
###begin article-title 128
A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion.
###end article-title 128
###begin article-title 129
Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage.
###end article-title 129
###begin article-title 130
Integrin-linked kinase and its partners: a modular platform regulating cell-matrix adhesion dynamics and cytoskeletal organization.
###end article-title 130
###begin article-title 131
Talin is required for integrin-mediated platelet function in hemostasis and thrombosis.
###end article-title 131
###begin article-title 132
Kindlin-3 is essential for integrin activation and platelet aggregation.
###end article-title 132
###begin article-title 133
The actin cytoskeleton differentially regulates platelet alpha-granule and dense-granule secretion.
###end article-title 133
###begin article-title 134
Integrin-linked kinase regulates chondrocyte shape and proliferation.
###end article-title 134

